Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection
Primary Purpose
Parastomal Hernia
Status
Completed
Phase
Phase 4
Locations
Spain
Study Type
Interventional
Intervention
laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25)
Sponsored by
About this trial
This is an interventional prevention trial for Parastomal Hernia focused on measuring Parastomal hernias, Tolerance of lightweight meshes, laparoscopic abdominoperineal resection
Eligibility Criteria
Inclusion Criteria:
- Patients of either sex intervened electively for colorectal surgery (rectal cancer) in whom definitive colostomy is indicated after laparoscopic abdominoperineal amputation.
- Life expectancy above 12 months
Exclusion Criteria:
- - Patients with allergy or intolerance of the compounds in the mesh
- Carriers of prosthetic meshes in the area of the ostomy
- Patients electively intervened for colorectal surgery (neo de reco) in whom definitive colostomy is indicated after abdominoperineal amputation but not via a laparoscopic approach.
- Cirrhotic patients
- Patients with life expectancy below 12 months due to underlying disease
Sites / Locations
- Corporacion Sanitaria Universitaria Parc Tauli
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Mesh Group
Control Group
Arm Description
Patients receiving conventional sigmoid end colostomy plus a preperitoneal lightweight mesh Physiomesh® by laparoscopic procedure
Patients receiving conventional sigmoid end colostomy by laparoscopic procedure, without mesh
Outcomes
Primary Outcome Measures
The reduction in the incidence of Parastomal Hernia after the mesh placement
Secondary Outcome Measures
Full Information
NCT ID
NCT01722565
First Posted
November 4, 2012
Last Updated
September 9, 2015
Sponsor
Corporacion Parc Tauli
1. Study Identification
Unique Protocol Identification Number
NCT01722565
Brief Title
Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection
Official Title
Randomized, Controlled, Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Corporacion Parc Tauli
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Introduction: parastomal hernia (PH) is a frequent complication after an ostomy, despite the many prevention and treatment techniques that have been described. Since the introduction of laparoscopy, the frequency of PH is even higher than in open surgery. This type of hernia remains a surgical problem of considerable importance, requiring significant consumption of public health and economic resources, and representing a major alteration of the quality of life of these patients.
Objective: to evaluate the effectiveness of the insertion of a prosthesis to prevent PH in elective surgery for laparoscopic abdominoperineal resection.
Methodology: prospective, multidisciplinary, multi-center randomized controlled study. Control group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection. Study group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25). Sample size was calculated based on a proportion of parastomal hernia of 65% in the control group and 15% in the study group. With an α risk =0.05 and 1- β= 0.8, 28 patients are required, 14 per group. Estimating a drop-out rate of 10%, the final number will be 32 patients. The efficacy will be evaluated clinically at six months and abdominal CT will be performed at 12 months along with another clinical evaluation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parastomal Hernia
Keywords
Parastomal hernias, Tolerance of lightweight meshes, laparoscopic abdominoperineal resection
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mesh Group
Arm Type
Experimental
Arm Description
Patients receiving conventional sigmoid end colostomy plus a preperitoneal lightweight mesh Physiomesh® by laparoscopic procedure
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients receiving conventional sigmoid end colostomy by laparoscopic procedure, without mesh
Intervention Type
Procedure
Intervention Name(s)
laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25)
Primary Outcome Measure Information:
Title
The reduction in the incidence of Parastomal Hernia after the mesh placement
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients of either sex intervened electively for colorectal surgery (rectal cancer) in whom definitive colostomy is indicated after laparoscopic abdominoperineal amputation.
Life expectancy above 12 months
Exclusion Criteria:
- Patients with allergy or intolerance of the compounds in the mesh
Carriers of prosthetic meshes in the area of the ostomy
Patients electively intervened for colorectal surgery (neo de reco) in whom definitive colostomy is indicated after abdominoperineal amputation but not via a laparoscopic approach.
Cirrhotic patients
Patients with life expectancy below 12 months due to underlying disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xavier Serra-Aracil, MD
Organizational Affiliation
Corporacion Sanitaria Universitaria Parc Tauli
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Manuel Lopez-Cano, MD
Organizational Affiliation
Hospital Vall d'Hebron
Official's Role
Principal Investigator
Facility Information:
Facility Name
Corporacion Sanitaria Universitaria Parc Tauli
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection
We'll reach out to this number within 24 hrs